Evogene Ltd. logo
Evogene Ltd. EVGN
$ 1.64 -0.75%

Annual report 2023
added 11-09-2024

report update icon

Evogene Ltd. Balance Sheet 2011-2024 | EVGN

Annual Balance Sheet Evogene Ltd.

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Net Debt

- - - - -3.44 M -3.24 M -10.2 M -5.21 M -95.5 M -24.3 M -

Long Term Debt

- - - - - - - - - - - - -

Long Term Debt Current

853 K 884 K 974 K 777 K 895 K - - - - - - - -

Total Non Current Liabilities

- - - 5.36 M 5.42 M 2.96 M 3.56 M 3.47 M 3.2 M 3.58 M 3.99 M 7.1 M -

Total Current Liabilities

- - - - - - - - - - - - -

Total Liabilities

- - - 15 M 11.1 M 8.39 M 8.22 M 8.7 M 8.84 M 11.5 M 12.6 M 16.6 M -

Deferred Revenue

- - - 119 K 386 K 412 K 516 K 967 K 560 K 1.51 M 1.57 M 4.94 M -

Retained Earnings

- - - -179 M -156 M -138 M -117 M -96.2 M -76.6 M -59.4 M -44.9 M -36 M -

Total Assets

51.1 M 56.1 M 76.3 M 71.9 M 71.4 M 58.7 M 77.6 M 96 M 113 M 128 M 137 M 64.9 M -

Cash and Cash Equivalents

20.8 M 29 M 32.3 M 46.2 M 34.7 M 5.81 M 3.44 M 3.24 M 10.2 M - - - -

Book Value

- - 76.3 M 56.9 M 60.2 M 50.3 M 69.4 M 87.3 M 104 M 116 M 125 M 48.3 M -

Total Shareholders Equity

- - - 56.9 M 60.2 M 50.3 M 69.4 M 87.3 M - - - - -

All numbers in USD currency

Quarterly Balance Sheet Evogene Ltd.

2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Long Term Debt

- - - - 1.7 M - 1.6 M - 1.66 M - 1.79 M - 2.08 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Non Current Liabilities

- - - - 6 M - 5.57 M - 5.36 M - 5.31 M - 5.4 M - - - 2.96 M - - - 3.56 M - - - 3.47 M - - - - - - - - - - - - - - - - - - - - - - -

Total Liabilities

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Deferred Revenue

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Retained Earnings

- - - - -207 M - -192 M - -179 M - -166 M - -156 M - - - -138 M - - - -117 M - - - -96.2 M - - - - - - - - - - - - - - - - - - - - - - -

Total Assets

- - - - 76.3 M - 87.5 M - 71.9 M - 61.1 M - 71.4 M - - - 58.7 M - - - 77.6 M - - - 96 M - - - - - - - - - - - - - - - - - - - - - - -

Cash and Cash Equivalents

- - - - 32.3 M - 42.8 M - 46.2 M - 31.1 M - 34.7 M - 14.1 M - 5.81 M - - - 3.44 M - - - 3.24 M - - - 10.2 M - - - 5.21 M - - - - - - - - - - - - - - -

Book Value

- - - - 76.3 M - 87.5 M - 71.9 M - 61.1 M - 71.4 M - - - 58.7 M - - - 77.6 M - - - 96 M - - - - - - - - - - - - - - - - - - - - - - -

Total Shareholders Equity

- - - - 63.4 M - 76.6 M - 56.9 M - 51 M - 60.2 M - 42.9 M - 50.3 M - - - 69.4 M - - - 87.3 M - - - 104 M - - - 116 M - - - - - - - - - - - - - - -

All numbers in USD currency